ICD-10 Coding for Thrombocytopenia(D69.0, D69.3, D69.3B)
Comprehensive guide to ICD-10 coding for thrombocytopenia, including immune and secondary forms. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Thrombocytopenia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D69.3 | Immune thrombocytopenic purpura (ITP) | Use when ITP is confirmed by exclusion of secondary causes. |
|
| D69.5 | Secondary thrombocytopenia | Use when thrombocytopenia is secondary to another condition or drug. |
|
| D69.6 | Unspecified thrombocytopenia | Use only when the specific cause of thrombocytopenia cannot be determined. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutThrombocytopenia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Thrombocytopenia.
Omitting the causative agent in secondary thrombocytopenia.
Impact
Clinical: Inaccurate treatment plans., Regulatory: Potential audit issues., Financial: Denial of claims.
Mitigation
Always document the causative agent., Use templates to ensure completeness.
Using D69.6 for ITP due to missing documentation.
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreased accuracy in patient records.
Mitigation
Query provider to confirm if it is immune or unspecified thrombocytopenia.
Unspecified Thrombocytopenia
Impact
High risk of audit if D69.6 is overused without proper documentation.
Mitigation
Ensure thorough documentation of workup and exclusion of specific causes.